FLT3 and acute myeloid leukemia: In the present study, the expressions of CD135, CD117, and CD135+CD117 were explored in 66 patients with AML, and they were shown to be expressed on the myoblasts of 77.3%, 84.8%, and 68.2% of patients with AML, respectively (Table 2).